Mackenzie Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.16M | Buy |
101,318
+2,337
| +2% | +$214K | 0.01% | 540 |
|
|
2025
Q4 | $8.97M | Buy |
98,981
+10,600
| +12% | +$1.01M | 0.01% | 528 |
|
|
2025
Q3 | $8.71M | Buy |
88,381
+17,661
| +25% | +$1.75M | 0.01% | 524 |
|
|
2025
Q2 | $6.45M | Buy |
70,720
+4,282
| +6% | +$414K | 0.01% | 555 |
|
|
2025
Q1 | $7.52M | Buy |
66,438
+6,547
| +11% | +$700K | 0.01% | 504 |
|
|
2024
Q4 | $6.33M | Buy |
59,891
+3,899
| +7% | +$418K | 0.01% | 538 |
|
|
2024
Q3 | $6.04M | Buy |
55,992
+6,789
| +14% | +$741K | 0.01% | 519 |
|
|
2024
Q2 | $5.34M | Sell |
49,203
-31,930
| -39% | -$3.76M | 0.01% | 534 |
|
|
2024
Q1 | $10.7M | Sell |
81,133
-36,457
| -31% | -$4.55M | 0.02% | 428 |
|
|
2023
Q4 | $14.3M | Buy |
117,590
+1,371
| +1% | +$153K | 0.02% | 386 |
|
|
2023
Q3 | $12.8M | Buy |
116,219
+1,839
| +2% | +$234K | 0.02% | 386 |
|
|
2023
Q2 | $16.3M | Buy |
114,380
+89,855
| +366% | +$12.2M | 0.02% | 368 |
|
|
2023
Q1 | $3.17M | Buy |
24,525
+252
| +1% | +$31.6K | ﹤0.01% | 641 |
|
|
2022
Q4 | $3.09M | Buy |
24,273
+2,236
| +10% | +$259K | 0.01% | 590 |
|
|
2022
Q3 | $2.3M | Sell |
22,037
-143,459
| -87% | -$15.7M | ﹤0.01% | 663 |
|
|
2022
Q2 | $17.4M | Sell |
165,496
-4,513
| -3% | -$535K | 0.03% | 344 |
|
|
2022
Q1 | $21.7M | Sell |
170,009
-3,810
| -2% | -$459K | 0.03% | 341 |
|
|
2021
Q4 | $21.4M | Sell |
173,819
-6,673
| -4% | -$873K | 0.03% | 347 |
|
|
2021
Q3 | $25.6M | Buy |
180,492
+9,884
| +6% | +$1.45M | 0.04% | 308 |
|
|
2021
Q2 | $26.6M | Buy |
170,608
+10,764
| +7% | +$1.74M | 0.04% | 298 |
|
|
2021
Q1 | $24.8M | Sell |
159,844
-22,837
| -13% | -$3.54M | 0.04% | 287 |
|
|
2020
Q4 | $27.3M | Sell |
182,681
-24,069
| -12% | -$3.4M | 0.06% | 231 |
|
|
2020
Q3 | $27.3M | Sell |
206,750
-2,937
| -1% | -$384K | 0.07% | 209 |
|
|
2020
Q2 | $24.3M | Sell |
209,687
-23,661
| -10% | -$2.73M | 0.07% | 214 |
|
|
2020
Q1 | $22.9M | Sell |
233,348
-137,462
| -37% | -$18M | 0.07% | 207 |
|
|
2019
Q4 | $53.9M | Sell |
370,810
-23,135
| -6% | -$3.19M | 0.13% | 165 |
|
|
2019
Q3 | $52.5M | Sell |
393,945
-164,075
| -29% | -$21.2M | 0.14% | 162 |
|
|
2019
Q2 | $63.8M | Buy |
558,020
+21,370
| +4% | +$2.5M | 0.16% | 146 |
|
|
2019
Q1 | $66.5M | Buy |
536,650
+217,039
| +68% | +$24.7M | 0.16% | 147 |
|
|
2018
Q4 | $32.2M | Buy |
319,611
+70,412
| +28% | +$7.92M | 0.08% | 201 |
|
|
2018
Q3 | $31.8M | Buy |
249,199
+14,913
| +6% | +$1.77M | 0.08% | 198 |
|
|
2018
Q2 | $25.3M | Buy |
234,286
+44,381
| +23% | +$4.83M | 0.06% | 212 |
|
|
2018
Q1 | $20.1M | Buy |
189,905
+75,750
| +66% | +$8.8M | 0.05% | 242 |
|
|
2017
Q4 | $13.4M | Buy |
114,155
+97,615
| +590% | +$11M | 0.03% | 308 |
|
|
2017
Q3 | $1.88M | Buy |
+16,540
| New | +$1.91M | 0.01% | 394 |
|
|
2017
Q2 | – | Sell |
-4,449
| Closed | -$527K | – | 679 |
|
|
2017
Q1 | $527K | Sell |
4,449
-5,762
| -56% | -$653K | ﹤0.01% | 520 |
|
|
2016
Q4 | $1.02M | Buy |
10,211
+3,687
| +57% | +$395K | 0.01% | 440 |
|
|
2016
Q3 | $824K | Sell |
6,524
-11,430
| -64% | -$1.41M | 0.01% | 438 |
|
|
2016
Q2 | $2.1M | Buy |
17,954
+33
| +0.2% | +$3.73K | 0.01% | 428 |
|
|
2016
Q1 | $1.85M | Buy |
17,921
+6,212
| +53% | +$601K | 0.02% | 366 |
|
|
2015
Q4 | $1.17M | Hold |
11,709
| – | – | 0.01% | 513 |
|
|
2015
Q3 | $1.07M | Sell |
11,709
-6,895
| -37% | -$691K | 0.01% | 525 |
|
|
2015
Q2 | $1.97M | Sell |
18,604
-4,266
| -19% | -$472K | 0.01% | 431 |
|
|
2015
Q1 | $2.61M | Sell |
22,870
-14,664
| -39% | -$1.67M | 0.01% | 387 |
|
|
2014
Q4 | $4.13M | Sell |
37,534
-6,341
| -14% | -$668K | 0.02% | 338 |
|
|
2014
Q3 | $4.28M | Buy |
43,875
+19,739
| +82% | +$1.94M | 0.02% | 327 |
|
|
2014
Q2 | $2.43M | Sell |
24,136
-515
| -2% | -$50.2K | 0.01% | 394 |
|
|
2014
Q1 | $2.26M | Buy |
24,651
+430
| +2% | +$39.6K | 0.01% | 384 |
|
|
2013
Q4 | $2.19M | Buy |
24,221
+3,609
| +18% | +$312K | 0.01% | 378 |
|
|
2013
Q3 | $1.64M | Sell |
20,612
-3,384
| -14% | -$266K | 0.01% | 401 |
|
|
2013
Q2 | $1.75M | Buy |
+23,996
| New | +$1.79M | 0.01% | 410 |
|
Other funds holding ZBH
VCM
VPM
Mackenzie Financial's ZBH Position: Q1 2026 in Review
Mackenzie Financial increased its Zimmer Biomet (ZBH) stake by 2.4% in Q1 2026, buying an estimated $214K and bringing the position to 101,318 shares worth $9.16M. The position accounts for 0.01% of the portfolio, ranked #540.
Mackenzie Financial first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $66.5M in Q1 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Mackenzie Financial held 101,318 shares of Zimmer Biomet worth $9.16M as of Q1 2026.
- Mackenzie Financial bought 2,337 Zimmer Biomet shares in Q1 2026, an estimated $214K.
- Zimmer Biomet made up 0.01% of Mackenzie Financial's portfolio in Q1 2026, its #540 holding.
- Mackenzie Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
- Mackenzie Financial's Zimmer Biomet position peaked at $66.5M in Q1 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.